secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001437749-24-037373
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva shareholders approve increase in authorized common stock from 115M to 315M; all director nominees elected.
--------------------------------------------------------------------------------

- Authorized common shares increased to 315M from 115M, effective December 10, 2024.
- All five director nominees (Bhat, Saxena, Margolin, Patel, Funtleyder) elected.
- Ratification of Moss Adams as auditor approved with 20.8M for, 1.7M against.
- Advisory say-on-pay approved (6.7M for); board set future advisory votes annually.
- Adjournment proposal not needed as share increase vote had sufficient votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924037373/0001437749-24-037373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924037373/rvph20241205_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-037373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer